{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:01:35Z","timestamp":1773280895993,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T00:00:00Z","timestamp":1565136000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00417-019-04417-9","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T19:02:14Z","timestamp":1565204534000},"page":"2185-2191","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Prophylactic intracameral cefazolin and postoperative topical moxifloxacin after cataract surgery: endophthalmitis risk reduction and safety results in a 16-year study"],"prefix":"10.1007","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2377-321X","authenticated-orcid":false,"given":"Carlos L.","family":"Moser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Lecumberri Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magela","family":"Garat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Mart\u00edn-Baranera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,8,7]]},"reference":[{"issue":"6","key":"4417_CR1","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jcrs.2007.02.032","volume":"33","author":"Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons","year":"2007","unstructured":"Endophthalmitis Study Group, European Society of Cataract & Refractive Surgeons (2007) Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg 33(6):978\u2013988","journal-title":"J Cataract Refract Surg"},{"issue":"9","key":"4417_CR2","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1016\/j.jcrs.2013.06.014","volume":"39","author":"A Behndig","year":"2013","unstructured":"Behndig A, Cochener B, G\u00fcell JL et al (2013) Endophthalmitis prophylaxis in cataract surgery: overview of current practice patterns in 9 European countries. J Cataract Refract Surg 39(9):1421\u20131431","journal-title":"J Cataract Refract Surg"},{"issue":"12","key":"4417_CR3","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1001\/archopht.1995.01100120009001","volume":"113","author":"Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study","year":"1995","unstructured":"Endophthalmitis Vitrectomy Study Group. Results of the Endophthalmitis Vitrectomy Study (1995) A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis. Arch Ophthalmol 113(12):1479\u20131496","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"4417_CR4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0886-3350(01)01269-X","volume":"28","author":"PG Montan","year":"2002","unstructured":"Montan PG, Wejde G, Koranyi G et al (2002) Prophylactic intracameral cefuroxime. Efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg 28(6):977\u2013981","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"4417_CR5","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/S0886-3350(01)01270-6","volume":"28","author":"PG Montan","year":"2002","unstructured":"Montan PG, Wejde G, Setterquist H et al (2002) Prophylactic intracameral cefuroxime. Evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg 28(6):982\u2013987","journal-title":"J Cataract Refract Surg"},{"issue":"11","key":"4417_CR6","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1016\/j.jcrs.2005.08.053","volume":"31","author":"M Garat","year":"2005","unstructured":"Garat M, Moser CL, Alonso-Tarr\u00e9s C et al (2005) Intracameral cefazolin to prevent endophthalmitis in cataract surgery: 3-year retrospective study. J Cataract Refract Surg 31(11):2230\u20132234","journal-title":"J Cataract Refract Surg"},{"issue":"4","key":"4417_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jcrs.2008.12.023","volume":"35","author":"M Garat","year":"2009","unstructured":"Garat M, Moser CL, Mart\u00edn-Baranera M et al (2009) Prophylactic intracameral cefazolin after cataract surgery: endophthalmitis risk reduction and safety results in a 6-year study. J Cataract Refract Surg 35(4):637\u2013642","journal-title":"J Cataract Refract Surg"},{"issue":"3","key":"4417_CR8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jcrs.2004.06.086","volume":"31","author":"JR Villada","year":"2005","unstructured":"Villada JR, Vicente U, Javaloy J et al (2005) Severe anaphylactic reaction after intracameral antibiotic administration during cataract surgery. J Cataract Refract Surg 31(3):620\u2013621","journal-title":"J Cataract Refract Surg"},{"issue":"12","key":"4417_CR9","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0161-6420(91)32052-9","volume":"98","author":"MG Speaker","year":"1991","unstructured":"Speaker MG, Menikoff JA (1991) Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 98(12):1769\u20131775","journal-title":"Ophthalmology."},{"issue":"1","key":"4417_CR10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0161-6420(01)00899-5","volume":"109","author":"TA Ciulla","year":"2002","unstructured":"Ciulla TA, Starr MB, Masket S (2002) Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. Ophthalmology. 109(1):13\u201324","journal-title":"Ophthalmology."},{"issue":"3","key":"4417_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jcrs.2017.01.007","volume":"43","author":"MR Silas","year":"2017","unstructured":"Silas MR, Schroeder RM, Thomson RB et al (2017) Optimizing the antisepsis protocol: effectiveness of 3 povidone-iodine 1.0% applications versus a single application of povidone-iodine 5.0. J Cataract Refract Surg 43(3):400\u2013404","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"4417_CR12","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.jcrs.2014.05.038","volume":"41","author":"S Sharma","year":"2015","unstructured":"Sharma S, Sahu SK, Dhillon V et al (2015) Reevaluating intracameral cefuroxime as a prophylaxis against endophthalmitis after cataract surgery in India. J Cataract Refract Surg 41(2):393\u2013399","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"4417_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jcrs.2012.10.037","volume":"39","author":"E Friling","year":"2013","unstructured":"Friling E, Lundstr\u00f6m M, Stenevi U et al (2013) Six-year incidence of endophthalmitis after cataract surgery: Swedish national study. J Cataract Refract Surg 39(1):15\u201321","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"4417_CR14","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jcrs.2006.09.019","volume":"33","author":"CR Espiritu","year":"2007","unstructured":"Espiritu CR, Caparas VL, Bolinao JG (2007) Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. Cataract Refract Surg 33(1):63\u201368","journal-title":"Cataract Refract Surg"},{"issue":"7","key":"4417_CR15","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.jcrs.2008.03.017","volume":"34","author":"LB Arbisser","year":"2008","unstructured":"Arbisser LB (2008) Safety of intracameral moxifloxacin for prophylaxis of endophthalmitis after cataract surgery. J Cataract Refract Surg 34(7):1114\u20131120","journal-title":"J Cataract Refract Surg"},{"issue":"6","key":"4417_CR16","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/j.ophtha.2017.01.026","volume":"124","author":"A Haripriya","year":"2017","unstructured":"Haripriya A, Chang DF, Ravindran RD (2017) Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600\u2009000 surgeries. Ophthalmology 124(6):768\u2013775","journal-title":"Ophthalmology"},{"issue":"12","key":"4417_CR17","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1016\/j.jcrs.2016.10.017","volume":"42","author":"SA Arshinoff","year":"2016","unstructured":"Arshinoff SA, Modabber M (2016) Dose and administration of intracameral moxifloxacin for prophylaxis of postoperative endophthalmitis. J Cataract Refract Surg 42(12):1730\u20131741","journal-title":"J Cataract Refract Surg"},{"key":"4417_CR18","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.jcrs.2008.05.045","volume":"34","author":"MK Jensen","year":"2008","unstructured":"Jensen MK, Fiscella RG, Moshirfar M et al (2008) Third-and fourth-generation fluoroquinolones: retrospective comparison of endophthalmitis after cataract surgery performed over 10 years. J Cataract Refract Surg 34:1460\u20131467","journal-title":"J Cataract Refract Surg"},{"key":"4417_CR19","first-page":"123","volume":"48","author":"AR Anand","year":"2000","unstructured":"Anand AR, Therese KL, Madhavan HN (2000) Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates. Indian J Ophthalmol 48:123","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"4417_CR20","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/ceo.12910","volume":"45","author":"GR Slean","year":"2017","unstructured":"Slean GR, Shorstein NH, Liu L et al (2017) Pathogens and antibiotic sensitivities in endophthalmitis. Clin Exp Ophthalmol 45(5):481\u2013488","journal-title":"Clin Exp Ophthalmol"},{"issue":"1","key":"4417_CR21","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1159\/000266764","volume":"21","author":"G Petroutsos","year":"1989","unstructured":"Petroutsos G, Savoldelli M, Pouliquen Y (1989) Effect of cefazolin on the corneal endothelium. An experimental study. Ophthalmic Res 21(1):33\u201336","journal-title":"Ophthalmic Res"},{"issue":"12","key":"4417_CR22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1471-2415-12-2","volume":"24","author":"P Romero-Aroca","year":"2012","unstructured":"Romero-Aroca P, M\u00e9ndez-Marin I, Salvat-Serra M et al (2012) Results at seven years after the use of intracamerular cefazolin as an endophthalmitis prophylaxis in cataract surgery. BMC Ophthalmol 24(12):2","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"4417_CR23","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.jcrs.2011.09.040","volume":"38","author":"CS Tan","year":"2012","unstructured":"Tan CS, Wong HK, Yang FP (2012) Epidemiology of postoperative endophthalmitis in an Asian population: 11-year incidence and effect of intracameral antibiotic agents. J Cataract Refract Surg 38(3):425\u2013430","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"4417_CR24","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ophtha.2015.08.039","volume":"123","author":"LJ Herrinton","year":"2016","unstructured":"Herrinton LJ, Shorstein NH, Paschal JF et al (2016) Comparative effectiveness of antibiotic prophylaxis in cataract surgery. Ophthalmology 123(2):287\u2013294","journal-title":"Ophthalmology"},{"key":"4417_CR25","unstructured":"Kim DH, Stark WJ, O\u2019Brien TP, Dick JD. (2005). Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology:112:1992\u20131996"},{"issue":"7","key":"4417_CR26","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.ophtha.2015.03.016","volume":"122","author":"AJ Witkin","year":"2015","unstructured":"Witkin AJ, Shah AR, Engstrom RE et al (2015) Postoperative hemorrhagic occlusive retinal vasculitis: expanding the clinical spectrum and possible association with vancomycin. Ophthalmology 122(7):1438\u20131451","journal-title":"Ophthalmology"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04417-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-019-04417-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-019-04417-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,5]],"date-time":"2020-08-05T23:08:02Z","timestamp":1596668882000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-019-04417-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,7]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4417"],"URL":"https:\/\/doi.org\/10.1007\/s00417-019-04417-9","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,7]]},"assertion":[{"value":"10 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in this study were routine clinical practice during the different study periods. Modifications in the prophylaxis protocol were in accordance with the ethical standards of the institutional infection committee. Informed consent before cataract surgery was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}